首页>British journal of ophthalmology>Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema
Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema
作者单位:University of Sydney,Univ Sydney[1]Ophthalmol Dept,Royal Free London NHS Fdn Trust[2]Dept Ophthalmol,Ctr Eye Res Australia Ltd[3]Lions Eye Inst,Univ Western Australia[4]